Skip to main content

Table 3 Characteristics of Circle participants with eGFR = > 60 by degree of albuminuria

From: Prevalence, determinants and co-morbidities of chronic kidney disease among First Nations adults with diabetes: results from the CIRCLE study

PARAMETER*

People With eGFR = > 60 and Urine Albumin (UA) Test

 

Total With UA

UA neg (non-CKD)

Micro-albuminuria**

Macro-albuminuria**

p

NUMBER (%)

583 (100)

242 (41.5)

247 (42.4)

94 (16.1)

…

% FEMALE

64.7

69.8

65.2

50.0

0.003

AGE AT AUDIT – mean (SD)

53.1 (13.8)

52.3 (13.6)

54.6 (14.0)

50.9 (13.5)

0.046

at diabetes diagnosis – mean (SD)

42.9 (13.1)

43.6 (12.8)

43.9 (132.1)

38.5 (13.2)

0.002

diabetes duration – mean (SD)

9.3 (6.7)

7.8 (5.9)

9.9 (7.0)

11.5 (7.2)

0.000

BODY MASS INDEX – mean (SD)

34.0 (6.8)

34.70 (6.4)

34.33 (7.4)

31.59 (5.7)

0.001

% SMOKER

41.6

42.2

36.7

52.2

0.04

BLOOD PRESSURE

     

sBP mm Hg – mean (SD)

131.4 (16.8)

128.7 (15.1)

133.5 (17.4)

132.7 (18.5)

0.004

dBP mm Hg – mean (SD)

76.2 (10.7)

75.9 (10.2)

77.0 (10.5)

75.11 (12.3)

n/s

BLOOD TESTS

     

AIC % – mean (SD)

8.28 (2.26)

7.72 (1.92)

8.34 (2.21)

9.58 (2.64)

0.000

TC mM – mean (SD)

4.51 (1.04)

4.38 (0.93)

4.49 (1.01)

4.93 (1.24)

0.000

LDL mM – mean (SD)

2.37 (1.82)

2.33 (0.77)

2.31 (0.81)

2.65 (0.93)

0.003

HDL mM – mean (SD)

1.22 (0.30)

1.20 (0.29)

1.20 (0.30)

1.30 (0.33)

0.017

COMORBIDITIES

     

% eye disease

11.5

7.4

13

18.1

0.015

% neuropathy

10.6

6.6

11.7

18.1

0.007

MEDICATIONS

     

% Insulin

28.5

19.4

33.2

39.4

0.000

% RAAS agents

74.6

67.4

75.7

90.4

0.000

  1. *sBP-systolic blood pressure, dBP-diastolic blood pressure, A1C-glycosylated hemoglobin, TC-total cholesterol, LDL-LDL cholesterol, HDL-HDL cholesterol, RAAS agents- containing angiotensin converting enzyme inhibitors or angiotensin receptor blockers.
  2. **Micro-albuminuria plus Macro-albuminuria. = CKD-alb.